Spots Global Cancer Trial Database for nut midline carcinoma (nmc)
Every month we try and update this database with for nut midline carcinoma (nmc) cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma | NCT03702036 | Solid Tumours | molibresib | 16 Years - | GlaxoSmithKline | |
A Dose Exploration Study With Birabresib (MK-8628) in Participants With Selected Advanced Solid Tumors (MK-8628-006) | NCT02698176 | NUT Midline Car... Triple Negative... Non-small Cell ... Castration-resi... | Birabresib | 18 Years - | Merck Sharp & Dohme LLC | |
Compassionate Use Individual Request Program for GSK525762 in NUT Midline Carcinoma | NCT03702036 | Solid Tumours | molibresib | 16 Years - | GlaxoSmithKline |